_edited.jpg)
CogniTrack
Dementia
We use the power of science for a brighter future, a clearer diagnosis, and a better life. This is not just a technology, it is an investment in human life.
.png)
Ongoing project
Not just a disease,
we also improve lives.
Lack of Early Diagnosis and Inadequate Tools
Dementia is usually advanced by the time symptoms are noticed. Traditional diagnostic methods rely heavily on subjective assessments and clinical observations, making it difficult to detect early symptoms. Furthermore, the lack of standardized tools based on objective biomarkers limits accurate and timely diagnosis. This negatively impacts the quality of life of both individuals and families, leading to missed opportunities for earlier intervention.
_edited.jpg)
New Generation Diagnostic Approach with Artificial Intelligence and VR
CogniTrack Dementia combines artificial intelligence and VR technologies to provide an innovative solution that detects early neurobiological signs of dementia. By analyzing eye movements and cognitive processes in real time, the system enables early diagnosis and provides diagnostic support to experts based on objective, scientific data. In this way, the disease process is managed more effectively and treatment plans can be personalized to the individual's needs.
Dementia
The Silent Epidemic of the Modern World
Dementia is a neurological disease that affects millions of people worldwide. As of 2024, 55 million people worldwide are living with dementia, with approximately 10 million new cases diagnosed each year. Alzheimer's disease, the most common form of dementia, accounts for 50% to 70% of all dementia cases. Alzheimer's is a progressive neurological disease that causes memory loss, impaired thinking skills, and loss of independence in daily activities. Studies show that the rate of Alzheimer's in individuals over the age of 65 ranges from 3% to 11%, while it reaches rates as high as 20% to 47% in individuals over the age of 85. In addition, the risk of Alzheimer's doubles every five years after the age of 65.
These diseases, which gradually lead to a decline in cognitive functions, seriously reduce the quality of life of individuals and increase the cost of care. Research shows that early diagnosis and effective care management have the potential to save 1 trillion USD annually. Therefore, innovative solutions for both dementia and Alzheimer's are a great need.
CogniTrack Dementia is a VR-based platform developed for the early diagnosis and management of dementia and Alzheimer's. It offers a fast, non-invasive and user-friendly solution through scientifically validated cognitive tests and games. This platform helps individuals maintain their cognitive health while providing an effective assessment process for physicians. CogniTrack Dementia aims to relieve the burden on individuals and healthcare systems by offering a comprehensive approach to combating Alzheimer's and dementia.